Latest Biotech Startup Funding Rounds

Financing for drug discovery, therapeutics and biological technologies, with the development context behind each round.

This page showsSector: Biotech
Rounds
603
All time
Disclosed funding
$28.7B
480 disclosed amounts
Median round
$17M
Of disclosed amounts
603 rounds
Funding rounds
CompanyAmountRoundSectorCountryInvestorsAnnounced
NucleraBiotech · United KingdomCompany profile

Provides rapid access to functional proteins through benchtop eProtein Discovery System

Provides rapid access to functional proteins through benchtop eProtein Discovery System

$12MSeries C+BiotechUnited KingdomInvestors
StarLIMSEnterprise software · United StatesCompany profile

Provides enterprise informatics platform for laboratories

Provides enterprise informatics platform for laboratories

UndisclosedUndisclosedBiotech, Enterprise softwareUnited StatesInvestors
Converge BioAI · United StatesCompany profile

AI platform for accelerated drug discovery and development

AI platform for accelerated drug discovery and development

$25MSeries ABiotech, AIUnited StatesInvestors
ProximaBiotech · United StatesCompany profile

Develops AI-driven drug discovery for proximity therapeutics

Develops AI-driven drug discovery for proximity therapeutics

$80MUndisclosedBiotechUnited StatesInvestors
Avenue BiosciencesBiotech · United StatesCompany profile

Develops high-throughput protein engineering technology for biologics manufacturing

Develops high-throughput protein engineering technology for biologics manufacturing

$5.7MSeed+SeedBiotechUnited StatesInvestors
FluoSpheraBiotech · SwitzerlandCompany profile

Develops human-based preclinical platform for drug safety and efficacy testing

Develops human-based preclinical platform for drug safety and efficacy testing

€1.2MUndisclosedBiotechSwitzerlandInvestors
Vibrant TherapeuticsBiotech · ChinaCompany profile

Develops intelligent, logic-gated therapeutics for solid tumors

Develops intelligent, logic-gated therapeutics for solid tumors

$61MSeries ABiotechChinaInvestors
NanochonBiotech · United StatesCompany profile

Develops implant for treating articular cartilage defects in the knee

Develops implant for treating articular cartilage defects in the knee

$4.1MSeed2SeedBiotechUnited StatesInvestors
VieCureHealthtech · United StatesCompany profile

Provides intelligent software platforms for oncology care

Provides intelligent software platforms for oncology care

$43MUndisclosedBiotech, HealthtechUnited StatesInvestors
Mirador TherapeuticsBiotech · United StatesCompany profile

Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases

Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases

$250MSeries BBiotechUnited StatesInvestors

Active investors in this selection

All investors →

Ranked by rounds participated in · All time

  1. 1
    RA Capital Management

    Delix Therapeutics, Alethio Therapeutics, Estuary Biotherapeutics

    27rounds
    6led
  2. 2
    Eli Lilly and Company

    Oyster Therapeutics, BigHat Biosciences, Circle Pharma, Inc.

    16rounds
    0led
  3. 3
    Janus Henderson Investors

    Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics

    16rounds
    1led
  4. 4
    ARCH Venture Partners

    Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences

    16rounds
    1led
  5. 5
    OrbiMed

    Dren Bio, Star Therapeutics, Leal Therapeutics

    12rounds
    1led

Latest digests

Archive →

Explore published rounds while the next edition is being prepared.

Browse rounds by topic